A. Kito

Most-cited papers

1. Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models

   Masayuki Suzuki, M. Takeda, A. Kito, M. Fukazawa +8 more

   2014Nutrition & Diabetes93 citations Open access

   Semantic Scholar

   Save

2. SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose

   Taku Fukuzawa, M. Fukazawa, O. Ueda, Hideaki Shimada +10 more

   2013PLoS ONE48 citations Open access

   Semantic Scholar

   Save

3. Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis

   T. Doki, Tomomi Takano, Kohei Kawagoe, A. Kito +1 more

   2015Research in Veterinary Science23 citations Open access

   Semantic Scholar

   Save

4. Class II lupus nephritis with podocyte injury in imiquimod-induced lupus-prone mice.

   Atsuko Murai, Masaki Yamazaki, Kaori Nishihara, A. Kito +3 more

   2022Histology and Histopathology5 citations

   Semantic Scholar

   Save

5. A simple specimen preparation method for histopathological evaluation of vestibular organs

   Shinichi Onishi, Atsuko Murai, A. Kito, Yuka Kawashima +2 more

   2022Journal of Toxicologic Pathology1 citations Open access

   Semantic Scholar

   Save

6. Regulatory insights on adeno-associated virus-based gene therapies, cell- and tissue-based products, and CAR-T cell therapies: report from the 8th Asia Partnership Conference of Regenerative Medicine, April 24, 2025

   Shunsuke Tominaga, Y. Tsurumaki, Yusuke Kagawa, A. Kito +5 more

   2026Regenerative Therapy0 citations Open access

   Semantic Scholar

   Save

7. Oral glucose tolerance test with WT mice (+/+) and SGLT5-deficient mice (−/−) given plain water or fructose water (HF).

   Taku Fukuzawa, M. Fukazawa, O. Ueda, Hideaki Shimada +10 more

   20130 citations Open access

   Semantic Scholar

   Save